Thomas Clozel M.D.
Dr Thomas Clozel leads Owkin as CEO. He is a former Assistant Professor of Clinical Onco-haematology at Hopital Henri Mondor in Paris and former member of Ari Melnick’s lab at the Weill Cornell Medical College. Clozel ensures that patient health is prioritised when developing breakthrough medical technologies, bringing a patient-centric approach to every Owkin project.
Contact info
- Website:
- https://www.owkin.com/
ArticleWhy AI models need patient data to deliver in drug discovery
Despite rapid advances in AI, many drug discovery models still struggle to translate computational predictions into clinical outcomes. Thomas Clozel explains how Owkin is training AI on large-scale patient-derived data while integrating experimental and clinical validation directly into model development.